52
ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Embed Size (px)

Citation preview

Page 1: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

ECHO CONFERENCE 5/11/11

DARRYN APPLETON

Ventricular Septal Defects

Page 2: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Outline

Morphology, Types & PathophysiologyNatural History and Clinical PresentationSome Echo examplesClinical Scenarios and RecommendationsInterventions: Indications, Surgery,

PercutaneousPregnancy and Endocarditis ProphylaxisReview Questions

Page 3: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Introduction

The most common form of CHD, accounting for up to 20-40% of patients diagnosed with CHD

Impact may range from asymptomatic to pulmonary HTN, LV volume overload and RVH

Morphology: 4 types Membranous – most common type in adults (80%) Muscular – most common type in young children Complete AV septal (endocardial cushion) defects Supracristal (subarterial)

Page 4: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Morphology – The Ventricular Septum

Page 5: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Morphology – The Ventricular Septum

1. Membranous2. Outflow3. Trabecular

septum4. Inflow5. Subarterial /

Supracristal

Page 6: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

VSD Types

Page 7: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

VSD Types

Page 8: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

VSD Types

Page 9: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Pathophysiology

Defect size is often compared to aortic annulus Large: > 50% of annulus size Medium: 25-50% of annulus size Small: <25% of annulus size

Page 10: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Pathophysiology

Restrictive VSD is typically small, such that a significant pressure gradient exists between the LV and RV (high velocity), with small shunt (Qp/Qs ≤ 1.4 : 1)

Moderately restrictive VSD moderate shunt (Qp/Qs 1.4 to 2.2 : 1)

Large / non-restrictive VSD large shunt (Qp/Qs > 2.2 : 1)

Eisenmenger VSD irreversible pulmonary HTN and shunt may be zero or reversed (i.e. RL)

Page 11: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Natural History

Restrictive: typically does not have hemodynamic impact and may close spontaneously Location Location Location: Subaortic may result in

progressive AI

Moderately restrictive: does create LV overload and dysfunction along with variable increase in PVR

Large / non-restrictive: LV volume overload earlier in life with progressive pulm HTN and ultimately Eisenmenger syndrome

Page 12: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Clinical Features

Peds: Murmur Dyspnea, CHF, Failure to thrive

Adults: Asymptomatic murmur – harsh, pansystolic, left

sternal border Mod restrictive – dyspnea, a.fib, displaced apex,

murmur, S3 Non-restrictive Eisenmenger VSD – central cyanosis,

clubbing, RV heave, loud P2

Page 13: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 1

Page 14: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 1

Page 15: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

t

Outlet VSD – Para long axis

Page 16: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 2

Page 17: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 2

Page 18: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 2

Page 19: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Supracristal VSD, with pulm outflow tract obstruction

Page 20: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 3

Page 21: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 3

Page 22: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 3

Page 23: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 3

Page 24: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 3

Page 25: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 3

Type: Size:

MembranousRestrictive

Page 26: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 4

Page 27: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 4

Page 28: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Echo Example 3

Type:Size: Shunt:

MuscularLarge / Non-restrictiveRL (inc RH pressures)RV dilatedEisenmengers

Page 29: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Clinical Scenarios & Recommendations

Symptomatic young infant with Pulm HTN Early surgery within 3 months. Medical therapy with diuretics +/- ACEI pre-op

Asymptomatic pt without Pulm HTN but with LV overload Closure usually recommended to avoid late LV dysfunction

Asymptomatic pt, small VSD, no LV dilation Conservative

Asymptomatic pt, small VSD but with AI/prolapse Peri-membranous VSD with more than trivial AI should

have surgery

Page 30: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Clinical Scenarios & Recommendations

Eisenmenger Syndrome Supportive Bosentan (Endothelin receptor antagonist) – improves

functional capacity, QOL Sildenafil

Penny DJ, Vick GW. Lancet 2011; 377: 1103-12

Page 31: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Interventions

Indications for Surgical Closure in adults: Evidence of LV volume overload (Class I if Qp/Qs >2,

Class IIa if Qp/Qs > 1.5) History of bacterial endocarditis (Class I) Significant LR shunt with PA pressure < 2/3 systemic

and PVR is < 2/3 SVR

Surgical Closure Considered the first-line choice of therapy for those

with indications Usually involves direct patch closure w cardio-pulm

bypass Operative mortality < 2% in most centers

Page 32: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Long Term Surgical Outcomes

Retrospective review of 46 pts with surgical VSD repair at Mayo Clinic

Mongeon et al. JACC Int 2010; 3: 290-7

Page 33: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Interventional Options

Percutaneous Device Closure Muscular VSDs can typically be closed percutaneously

Class IIb recommendation in Guidelines (i.e. surgery still preferred)

No FDA approved devices for perimembranous VSDs, although there are specific devices for this purpose Concern re proximity of defect to AV node and high risk

of complete AV block requiring pacemaker

Page 34: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Pregnancy and VSDs

Pregnancy well tolerated in women with small to moderate sized VSDs as long as there is no pulmonary vascular involvement

Eisenmenger syndrome: Pregnancy contraindicated due to exceptionally high risk of maternal and fetal death

Page 35: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Endocarditis Prophylaxis for VSD

Uncomplicated VSD – no Abx for dental or other procedures required

Post repair: Abx for 6 months following surgical or percutaneous

repair Indefinite Abx if there is residual shunt

Risk of bacteremia from daily life usually exceeds that of procedure Abx for procedures only prevent small % of cases

Focus should be on optimal dental hygiene for those with CHD

Page 36: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 1

An isolated VSD will generally cause enlargement of which chamber(s): A: Left atrium, left ventricle B: Right ventricle C: Right ventricle, pulmonary artery D: Aorta E: Right ventricle, right atrium

Page 37: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 1

An isolated VSD will generally cause enlargement of which chamber(s): A: Left atrium, left ventricle B: Right ventricle C: Right ventricle, pulmonary artery D: Aorta E: Right ventricle, right atrium

Page 38: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 2

Page 39: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 2

The defect shown on the previous slide is a: A: Muscular VSD B: Sinus venosus VSD C: Perimembranous VSD D: Inlet VSD E: Supracristal VSD

Page 40: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 2

The defect shown on the previous slide is a: A: Muscular VSD B: Sinus venosus VSD C: Perimembranous VSD D: Inlet VSD E: Supracristal VSD

Page 41: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 3

A common complication of this defect is: A: Pulmonary valve endocarditis B: Aortic regurgitation C: Aortic dissection D: Tricuspid regurgitation E: Right ventricular enlargement

Page 42: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 3

A common complication of this defect is: A: Pulmonary valve endocarditis B: Aortic regurgitation C: Aortic dissection D: Tricuspid regurgitation E: Right ventricular enlargement

Page 43: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 4

There is no diastolic flow in this perimembranous VSD A: True B: False

Page 44: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 4

There is no diastolic flow in this perimembranous VSD A: True B: False

Page 45: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 5

A restrictive VSD is a simple lesion with a good long term prognosis. However, complications can occur. All of the following are possible complications of a VSD except: A: Endocarditis B: Aortic regurgitation C: Aortic valve prolapse D: Eisenmenger Syndrome E: Right sided volume overload

Page 46: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 5

A restrictive VSD is a simple lesion with a good long term prognosis. However, complications can occur. All of the following are possible complications of a VSD except: A: Endocarditis B: Aortic regurgitation C: Aortic valve prolapse D: Eisenmenger Syndrome E: Right sided volume overload

Page 47: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 6

Page 48: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 6

The pulmonary artery systolic pressure in this patient with a VSD is: A: Normal B: Moderately elevated C: Systemic / Supra-systemic

Page 49: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 6

The pulmonary artery systolic pressure in this patient with a VSD is: A: Normal B: Moderately elevated C: Systemic / Supra-systemic

Page 50: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 7

A patient with a VSD undergoes TTE. BP measured at the time of the study is 125/75 (right arm), MAP 92. CW doppler across the VSD gives a peak velocity of 5 m/s. Assuming RA pressure of 5, what is the estimated PASP? A: 20mmHg B: 25 mmHg C: 30 mmHg D: 72 mmHg E: 105 mmHg

Page 51: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

Question 7

A patient with a VSD undergoes TTE. BP measured at the time of the study is 125/75 (right arm), MAP 92. CW doppler across the VSD gives a peak velocity of 5 m/s. Assuming RA pressure of 5, what is the estimated PASP? A: 20mmHg B: 25 mmHg C: 30 mmHg D: 72 mmHg E: 105 mmHg

Page 52: ECHO CONFERENCE 5/11/11 DARRYN APPLETON Ventricular Septal Defects

VSD Hemodynamics

Peak gradient = 4 x v2 (Simplied Bernoulli equation)

VSD gradient = LV systolic pressure – RV systolic pressure

RVSP = LVSP - VSD gradient RVSP = cuff systolic BP - VSD gradient (or 4

x v2)

Assuming no aortic outflow tract obstruction

PASP = RVSP Assuming no pulmonary outflow tract obstruction